Dr. Thaju Salam, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St Ste 350, Merriam, KS 66204 Phone: 913-632-9400 Fax: 913-632-9444 |
John Paul Lecluyse, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 9100 W 74th St, Merriam, KS 66204 Phone: 913-632-9400 |
Andrew Sebastian Waters, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St Ste 350, Merriam, KS 66204 Phone: 913-632-9400 Fax: 913-632-9444 |
Matthew Bryan Earnest, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St Ste 350, Merriam, KS 66204 Phone: 913-632-9400 Fax: 913-632-9444 |
Dr. Anthony A Albracht, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9119 W 74th St Ste 350, Merriam, KS 66204 Phone: 913-632-9400 Fax: 913-632-9444 |
News Archive
Scientists have for the first time sequenced and reconstructed the genomes of most of the microbes in the gut of a premature newborn and documented how the microbe populations changed over time.
SciClone Pharmaceuticals, Inc. today announced a corporate restructuring that will reduce its U.S.-based workforce by approximately 17%, primarily in research and development. This restructuring follows the discontinuation of SciClone's RP101 phase 2 clinical trial announced on October 2, 2009.
GfK Healthcare's Roper Global Diabetes Programme, the definitive global perspective on diabetes, announced today the launch of its enhanced 2009/2010 Western Europe Patient Study. Offering a holistic perspective of the diabetes patient across five European countries, with robust insights into patients' attitudes and behaviors towards treatments, testing and lifestyles, the study now makes available to marketers greater reporting frequency and focus across a variety of broad-based and niche diabetes patient groups.
A research team from the University of Melbourne is working on a new therapy that can potentially control the pain caused by diseases such as rheumatoid arthritis and osteoarthritis.
A new study by researchers from Brigham and Women's Hospital in Boston, Massachusetts reveals that Asian and Hispanic patients with systemic lupus erythematosus (SLE) have lower mortality rates compared to Black, White, or Native Americans with the disease.
› Verified 1 days ago